ADVENZYMES — Advanced Enzyme Technologies Cashflow Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousMid CapHigh Flyer

Annual cashflow statement for Advanced Enzyme Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	C2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,620	1,792	2,104	1,711	1,404
Depreciation
Non-Cash Items	49	24.5	-41.5	-18.2	19.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-594	-665	-711	-819	-370
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,286	1,409	1,635	1,223	1,404
Capital Expenditures	-124	-507	-194	-281	-381
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,123	61.5	-65.9	243	-2,601
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-1,247	-445	-260	-37.9	-2,982
Financing Cash Flow Items	-38.7	-24.9	-15.4	-229	-92.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-431	-386	-263	-485	-258
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-381	596	1,093	754	-1,709